FIELD: biotechnology.
SUBSTANCE: present invention relates to a method, which allows for introduction of active ingredients, in particular nucleic acids, into cells with better efficiency; and to cationic lipids, etc. for use in this method. A new compound corresponds to the formula (I), in which n is an integer from 2 to 5, R is a linear C1-5 alkyl group, linear C7-11 alkenyl group, or linear C11 alkadienyl group, and wavy lines in each case are independently a cis-bond or trans-bond, or its pharmaceutically acceptable salt.
EFFECT: obtaining cationic lipids.
8 cl, 7 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CATIONIC LIPID | 2019 |
|
RU2784335C2 |
| TRIALKYL CATIONIC LIPIDS AND METHODS FOR USING THEM | 2013 |
|
RU2718053C2 |
| CATIONIC LIPID | 2017 |
|
RU2740921C2 |
| LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS | 2013 |
|
RU2658007C2 |
| METHOD OF T-CELL ACTIVATION/PROLIFERATION | 2019 |
|
RU2806549C2 |
| IONIZABLE LIPIDS AND COMPOSITIONS THEREOF IN FORM OF NANOPARTICLES | 2020 |
|
RU2836646C1 |
| COMPOUNDS FOR TARGETED DRUG DELIVERY AND ENHANCING siRNA ACTIVITY | 2012 |
|
RU2769872C2 |
| ANTICANCER RNA VACCINES | 2017 |
|
RU2768829C2 |
| COMPOUNDS FOR TARGETED DELIVERY OF MEDICINE AND ENHANCED SIPHK ACTIVITY | 2012 |
|
RU2632888C2 |
| POLYNUCLEOTIDES CODING INTERLEUKIN-12 (IL12), AND APPLICATIONS THEREOF | 2017 |
|
RU2769316C2 |
Authors
Dates
2022-10-24—Published
2018-12-27—Filed